Research Finds Cannabis Effective for Migraines
Cannabis preparations are likely effective at preventing and treating migraines, according to a recently published review of available research.
Cannabis preparations are likely effective at preventing and treating migraines, according to a recently published review of available research.
Cannabis preparations are likely effective at preventing and treating migraines, according to a recently published review of available research.
Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache, as compared to arthritis and chronic pain, and to analyze preferred cannabis strains, biochemical profiles, and prescription medication substitutions with cannabis.
Comprehensive literature reviews of historical perspectives and evidence supporting cannabis/cannabinoids in the treatment of pain, including migraine and headache, with associated neurobiological mechanisms of pain modulation have been well described. There is accumulating evidence for various therapeutic benefits of cannabis/cannabinoids, especially in the treatment of pain, which may also apply to the treatment of migraine and headache.
Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache, as compared to arthritis and chronic pain, and to analyze preferred cannabis strains, biochemical profiles, and prescription medication substitutions with cannabis.
Anxiety and migraine sufferers may get a chance to use medical cannabis as a treatment in the Garden State New Jersey’s notoriously strict medical marijuana program may be on the road to expansion, thanks to the approval of five new ailments as qualifying conditions for medical cannabis by state regulators. Patch reports that the state’s Medicinal Marijuana Review Panel…
The patient’s spouse, family, and other friends were more likely to know about their MC use than was their primary care provider. In conclusion, a majority of patients reported using less opioids as well as fewer medications to treat anxiety, migraines, and sleep after initiating MC. A smaller portion used less antidepressants or alcohol. Additional research is needed to corroborate these self-reported, retrospective, cross-sectional findings using other data sources.